Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC52180WAY-169916CAS: 669764-18-5Purity: >98.00%
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.
- GC52193EptifibatideCAS: 188627-80-7Purity: >98.00%
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
- GC52221EleclazineCAS: 1443211-72-0Purity: >98.00%
Eleclazine is a novel, highly selective inhibitor of the cardiac late sodium current, with an IC 50 value of <1μM.
- GC52250Mevalonate (lithium salt)CAS: 2618458-93-6Purity: >98.00%
Mevalonate (lithium salt) is a metabolic precursor of the mevalonate pathway.
- GC52254Thrombin-Sensitive Peptide (ammonium acetate salt)Purity: >95.00%
A synthetic peptide containing a thrombin-releasable quencher
- GC52281Losartan AzideCAS: 727718-93-6Purity: >95.00%
A potential impurity in commercial preparations of losartan
- GC52303Ethyl MycophenolateCAS: 32483-51-5Purity: >98.00%
A potential impurity found in commercial preparations of mycophenolate mofetil
- GC52310L-Arginine-13C6 (hydrochloride)CAS: 201740-91-2Purity: >98.50%
An internal standard for the quantification of L-arginine
- GC52318Oleic Acid-13C5CAS: 1255644-48-4Purity: >95.00%
An internal standard for the quantification of oleic acid
- GC523243-(3-Hydroxyphenyl)propionic Acid sulfateCAS: 86321-32-6Purity: >95.00%
A metabolite of certain phenols and glycosides
- GC52342P4pal10 (trifluoroacetate salt)Purity: >98.00%
A PAR4 and FPR2 antagonist and an FFAR2 agonist
- GC52351Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide
A biotinylated and citrullinated α-enolase peptide
- GC52384NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)Purity: >95.00%
A cell-permeable form of NFAT inhibitor
- GC52389Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)Purity: >95.00%
A synthetic peptide fragment of caveolin-1
- GC52390Spexin 1 (human, mouse, rat, bovine) (acetate)Purity: >98.00%
An endogenous peptide and agonist of GAL 2 and GAL 3
- GC52404γ-Glu-Phe (trifluoroacetate salt)Purity: >98.00%
A dipeptide with metabolism-altering activity
- GC52415Angiotensin A (trifluoroacetate salt)Purity: >98.00%
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52177 | Perphenazine Sulfoxide | 10078-25-8 | >98.00% | |
| GC52180 | WAY-169916 | 669764-18-5 | >98.00% | |
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity. | ||||
| GC52193 | Eptifibatide | 188627-80-7 | >98.00% | |
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity. | ||||
| GC52198 | 9,11-methane-epoxy Prostaglandin F1α | 72517-81-8 | >96.00% | |
| GC52201 | 16-phenyl tetranor Prostaglandin E2 | 38315-44-5 | >99.00% | |
| GC52221 | Eleclazine | 1443211-72-0 | >98.00% | |
Eleclazine is a novel, highly selective inhibitor of the cardiac late sodium current, with an IC 50 value of <1μM. | ||||
| GC52250 | Mevalonate (lithium salt) | 2618458-93-6 | >98.00% | |
Mevalonate (lithium salt) is a metabolic precursor of the mevalonate pathway. | ||||
| GC52254 | Thrombin-Sensitive Peptide (ammonium acetate salt) | - | >95.00% | |
A synthetic peptide containing a thrombin-releasable quencher | ||||
| GC52281 | Losartan Azide | 727718-93-6 | >95.00% | |
A potential impurity in commercial preparations of losartan | ||||
| GC52303 | Ethyl Mycophenolate | 32483-51-5 | >98.00% | |
A potential impurity found in commercial preparations of mycophenolate mofetil | ||||
| GC52310 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | >98.50% | |
An internal standard for the quantification of L-arginine | ||||
| GC52318 | Oleic Acid-13C5 | 1255644-48-4 | >95.00% | |
An internal standard for the quantification of oleic acid | ||||
| GC52324 | 3-(3-Hydroxyphenyl)propionic Acid sulfate | 86321-32-6 | >95.00% | |
A metabolite of certain phenols and glycosides | ||||
| GC52327 | Ciraparantag (trifluoroacetate salt) | - | >95.00% | |
An anticoagulant reversal agent | ||||
| GC52342 | P4pal10 (trifluoroacetate salt) | - | >98.00% | |
A PAR4 and FPR2 antagonist and an FFAR2 agonist | ||||
| GC52351 | Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide | - | - | |
A biotinylated and citrullinated α-enolase peptide | ||||
| GC52359 | ATX-100 | 2230647-37-5 | >98.00% | |
An ionizable cationic lipid | ||||
| GC52384 | NFAT Inhibitor (cell-permeable) (trifluoroacetate salt) | - | >95.00% | |
A cell-permeable form of NFAT inhibitor | ||||
| GC52388 | [D-Lys3]-GHRP-6 (trifluoroacetate salt) | - | >95.00% | |
An antagonist of GHS-R1a | ||||
| GC52389 | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >95.00% | |
A synthetic peptide fragment of caveolin-1 | ||||
| GC52390 | Spexin 1 (human, mouse, rat, bovine) (acetate) | - | >98.00% | |
An endogenous peptide and agonist of GAL 2 and GAL 3 | ||||
| GC52400 | γ-Glu-Ala (trifluoroacetate salt) | - | >95.00% | |
A dipeptide | ||||
| GC52404 | γ-Glu-Phe (trifluoroacetate salt) | - | >98.00% | |
A dipeptide with metabolism-altering activity | ||||
| GC52415 | Angiotensin A (trifluoroacetate salt) | - | >98.00% | |
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II | ||||